✦ LIBER ✦

Pharmacovigilance and biosimilars: considerations, needs and challenges

✍ Scribed by Casadevall, Nicole; Edwards, I Ralph; Felix, Thomas; Graze, Peter R; Litten, Jason B; Strober, Bruce E; Warnock, David G

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comparative testing and pharmacovigilanc

✍ Locatelli, F. 📂 Article 📅 2006 🏛 Oxford University Press 🌐 English ⚖ 81 KB

Biologic product identification and US p

✍ Felix, Thomas; Johansson, Torbjörn T; Colliatie, Jodi A; Goldberg, Michael R; Fo 📂 Article 📅 2014 🏛 Nature Publishing Group 🌐 English ⚖ 132 KB

New and Generic Anticoagulants and Biosi

✍ Kalodiki, E.; Fareed, J. 📂 Article 📅 2010 🏛 SAGE Publications 🌐 English ⚖ 117 KB

Technical challenges in designing post-m

✍ Zhengwu Lu 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 349 KB

15 INVITED Open questions about biosimil

✍ H. Mellstedt; H. Ludwig; D. Niederwieser 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 72 KB

Comparability and biosimilarity: conside

✍ Lee, Jaymi F.; Litten, Jason B.; Grampp, Gustavo 📂 Article 📅 2012 🏛 Informa plc 🌐 English ⚖ 396 KB